Challenges for taking primary and stem cells into clinical neurotransplantation trials for neurodegenerative disease.
about
Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectivesCharacterization of ectopic colonies that form in widespread areas of the nervous system with neural stem cell transplants into the site of a severe spinal cord injuryDifferentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient.Stem cells for cell replacement therapy: a therapeutic strategy for HD?Engraftment of enteric neural progenitor cells into the injured adult brain.Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?Human-animal chimera: a neuro driven discussion? Comparison of three leading European research countries.Carriers in cell-based therapies for neurological disorders.Nicotinamide alone accelerates the conversion of mouse embryonic stem cells into mature neuronal populations.Targeting human oligodendrocyte progenitors for myelin repair.Temporal establishment of neural cell identity in vivo and in vitro.Current Understanding of the Pathways Involved in Adult Stem and Progenitor Cell Migration for Tissue Homeostasis and Repair.Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies.Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases.A commentary on "Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient"Continuous High-Frequency Stimulation of the Subthalamic Nucleus Improves Cell Survival and Functional Recovery Following Dopaminergic Cell Transplantation in Rodents.Thermoresponsive Copolypeptide Hydrogel Vehicles for Central Nervous System Cell Delivery.Deriving striatal projection neurons from human pluripotent stem cells with Activin A.Tackling Cell Transplantation Anoikis: An Injectable, Shape Memory Cryogel Microcarrier Platform Material for Stem Cell and Neuronal Cell Growth.Translation of cell therapies to the clinic: characteristics of cell suspensions in large-diameter injection cannulae.Development of Multifunctional Magnetic Nanoparticles for Genetic Engineering and Tracking of Neural Stem Cells.A Critical Evaluation of the Methodological Obstacles to Translating Cell-Based Research Into an Effective Treatment for People With Parkinson's Disease.Mesenchymal stem cells maintain the microenvironment of central nervous system by regulating the polarization of macrophages/microglia after traumatic brain injury.Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease.Ethical Challenges of Stem-Cell Transplantation in Parkinson's Disease: Islamic ViewpointAssessing the Efficacy of Cell Transplantation for Parkinson's Disease: A Patient-Centered Approach
P2860
Q28085612-CF6D9B03-0FFB-43C5-B768-347501BFCE5DQ34345673-180A26AD-5A58-4F2A-8F82-472F8A8011ACQ34608910-336C9A9D-F524-4789-91F1-C40A0DE37814Q35250495-32E155B2-C581-4DB1-8F23-68A714B1DD35Q35904481-79FEB0FB-1D0C-4D27-AFCA-86CFBCBAF3F1Q36264251-535412CF-63E0-484E-9CDE-61D145600A84Q38217150-55D87896-0626-4E2C-B1CC-D3D93C795486Q38220613-5031ABA3-E401-4760-8A8A-613A360DDDA0Q38694699-AC3853DE-FD85-4FD5-BA05-949E19EC8B1CQ38784277-BC095BC8-CC5D-43AB-B154-4950A67BFC5AQ38803144-8739CD50-3904-420B-9E55-EDBA34CB397EQ38840851-84004600-885D-42B2-B123-193C698A037FQ38873789-B6919D42-55AB-47D6-A74E-133885750BECQ38999340-2444BB43-CE79-42FB-B0E4-5D3E1F90AEB0Q40559755-F80E1729-B6E9-4D36-B1EB-106C3C93C50CQ41097001-4263BDBB-CE3E-4C4C-BDCB-E0D917779F33Q41554706-A4A4AB01-11A3-4773-A198-E4E720BFC701Q41864456-DE0658C1-4916-4C6A-A8D8-2E25E7ABDCF9Q42632568-F06DF143-D428-43B6-8D93-622B0CA1D4F2Q48456297-3943DB7E-DC4A-4ACA-A863-0F3F27A4C805Q48628755-A62C91EA-A7EC-426E-B7A7-C28D32B59D4FQ48858846-9890E9A4-CA94-4585-83FF-75429F5AA3ABQ51024048-69BF9919-50DA-40F1-AA10-2E862D2F63B3Q52568314-779BC56B-DB47-40EA-A3A5-CC13C6E11EF8Q58107046-87C46C2B-4632-4E1F-A153-3CC5F1595C98Q58779925-9A22F592-FBD5-4746-BACC-9CEEE5EB4956
P2860
Challenges for taking primary and stem cells into clinical neurotransplantation trials for neurodegenerative disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Challenges for taking primary ...... for neurodegenerative disease.
@ast
Challenges for taking primary ...... for neurodegenerative disease.
@en
Challenges for taking primary ...... for neurodegenerative disease.
@nl
type
label
Challenges for taking primary ...... for neurodegenerative disease.
@ast
Challenges for taking primary ...... for neurodegenerative disease.
@en
Challenges for taking primary ...... for neurodegenerative disease.
@nl
prefLabel
Challenges for taking primary ...... for neurodegenerative disease.
@ast
Challenges for taking primary ...... for neurodegenerative disease.
@en
Challenges for taking primary ...... for neurodegenerative disease.
@nl
P1476
Challenges for taking primary ...... for neurodegenerative disease
@en
P2093
Anne E Rosser
Stephen B Dunnett
P356
10.1016/J.NBD.2013.05.004
P577
2013-05-18T00:00:00Z